EFFECTS OF CYP2D6 AND CYP3A5 GENOTYPES ON THE PLASMA CONCENTRATIONS OF RISPERIDONE AND 9-HYDROXYRISPERIDONE IN KOREAN SCHIZOPHRENIC PATIENTS.

被引：0
|
作者：
Kang, R. [1 ]
Jung, S. [2 ]
Kim, K. [3 ]
Lee, D. [2 ]
Cho, H. [2 ]
Jung, B. [2 ]
Lee, M. [1 ]
Park, J. [3 ]
机构：
[1] Korea Univ, Coll Med, Dept Psychiat, Seoul 136705, South Korea
[2] Yangsan Neuropsychiat Hosp, Dept Psychiat, Yangsan, South Korea
[3] Korea Univ, Coll Med, Dept Clin Pharmacol & Toxicol, Seoul 136705, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2009年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S77 / S77
页数：1
相关论文
共 50 条
  • [41] CYP2D6, CYP3A5, and CYP3A4 Gene Polymorphisms in Russian, Tatar, and Bashkir Populations
    Mustafina, O. E.
    Tuktarova, I. A.
    Karimov, D. D.
    Somova, R. Sh.
    Nasibullin, T. R.
    RUSSIAN JOURNAL OF GENETICS, 2015, 51 (01) : 98 - 107
  • [42] Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects
    Zheng, T.
    Su, C. H.
    Zhao, J.
    Zhang, X. J.
    Zhang, T. Y.
    Zhang, L. R.
    Kan, Q. C.
    Zhang, S. J.
    PHARMAZIE, 2013, 68 (04): : 257 - 260
  • [43] PHARMACOGENETIC ANALYSIS OF CYP2D6, CYP3A4, CYP3A5, AND CYP2C9 AMONG THE CONFEDERATED SALISH AND KOOTENAI TRIBES IN MONTANA
    Woodahl, E. L.
    Fohner, A.
    Muzquiz, L. L.
    Austin, M.
    Gaedigk, A.
    Gordon, A.
    Rieder, M. J.
    Pershouse, M. A.
    Putnam, E. A.
    Howlett, K.
    Beatty, P.
    Thummel, K. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S97 - S97
  • [44] Effects of the CYP2D6 genotypes on the pharmacokinetics of atomoxetine
    Choi, Chang-Ik
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    FASEB JOURNAL, 2011, 25
  • [45] CYP3A5 but not CYP2D6 polymorphism affects dextropropoxyphene disposition in human subjects.
    Chow, MS
    Yin, OQ
    Tomlinson, B
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P50 - P50
  • [46] Impact of CYP2D6*2A, CYP2D6*4 and CYP3A5*3 genetic polymorphisms on Bisoprolol peak concentration and clinical response in acute coronary syndrome patients
    Okda, Sherouk M.
    El-Bassiouny, Noha A.
    El Amrawy, Ahmed Mahmoud
    Salahuddin, Ahmad
    Elonsy, Sohila M.
    Kassem, Amira B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (10) : 2539 - 2553
  • [47] Genetic polymorphism of cytochromes P450, CYP2D6, CYP2C9 and CYP3A5 in he Greek population
    Ragia, G. G.
    Arvanitidis, K. I.
    Tsamadias, V. L.
    Iordanidou, M. P.
    Kyriaki, S. A.
    Manolopoulos, V. G.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 235 - 235
  • [48] Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray
    Dong, Yuanyuan
    Xiao, Huasheng
    Wang, Qi
    Zhang, Chunxiu
    Liu, Xiuming
    Yao, Na
    Sheng, Haihui
    Li, Haiyan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18917 - 18926
  • [49] Effect of CYP2D6, CYP2C9 and ABCB1 genotypes on fluoxetine plasma concentrations and clinical improvement in children and adolescent patients
    P Gassó
    N Rodríguez
    S Mas
    M Pagerols
    A Blázquez
    M T Plana
    M Torra
    L Lázaro
    A Lafuente
    The Pharmacogenomics Journal, 2014, 14 : 457 - 462
  • [50] Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations
    Ma, Lingyue
    Xiang, Qian
    Zhao, Nan
    Hu, Changqing
    Fang, Meng
    Tan, Yunlong
    Chen, Song
    Wang, Zining
    Liu, Pinglan
    Sun, Kaoxiang
    Li, Youxin
    Wu, Fuxi
    Tian, Hongjun
    Fang, Maosheng
    Zhao, Xia
    Wang, Gang
    Cui, Yimin
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 109
12345